| Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell G Kildisiute, WM Kholosy, MD Young, K Roberts, R Elmentaite, ... Science advances 7 (6), eabd3311, 2021 | 102 | 2021 |
| TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets B Decaesteker, G Denecker, C Van Neste, EM Dolman, W Van Loocke, ... Nature communications 9 (1), 4866, 2018 | 90 | 2018 |
| G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment PM Sanz, DJ van Rees, LMJ van Zogchel, B Klein, P Bouti, H Olsman, ... Journal for ImmunoTherapy of Cancer 9 (5), 2021 | 24 | 2021 |
| Anti-GD2-IRDye800CW as a targeted probe for fluorescence-guided surgery in neuroblastoma LM Wellens, MM Deken, CFM Sier, HR Johnson, F de la Jara Ortiz, ... Scientific Reports 10 (1), 17667, 2020 | 22 | 2020 |
| Neuroblastoma and DIPG organoid coculture system for personalized assessment of novel anticancer immunotherapies W M. Kholosy, M Derieppe, F van den Ham, K Ober, Y Su, L Custers, ... Journal of personalized medicine 11 (9), 869, 2021 | 20 | 2021 |
| Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cells WM Kholosy, M Visscher, K Ogink, H Buttstedt, K Griffin, A Beier, ... Journal of Biotechnology 338, 71-80, 2021 | 17 | 2021 |
| αβ-T cells engineered to express γδ-T cell receptors can kill neuroblastoma organoids independent of MHC-I expression JGM Strijker, R Pscheid, E Drent, JJF van der Hoek, B Koopmans, K Ober, ... Journal of personalized medicine 11 (9), 923, 2021 | 10 | 2021 |
| Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy J Wienke, LL Visser, WM Kholosy, KM Keller, M Barisa, E Poon, ... Cancer Cell, 2024 | 6 | 2024 |
| Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy J Wienke, LL Visser, WM Kholosy, KM Keller, M Barisa, ... bioRxiv, 2022.07. 15.499859, 2022 | 1 | 2022 |
| Report–Tumor to normal single cell mRNA comparisons reveal a pan-neuroblastoma cancer cell G Kildisiute, WM Kholosy, MD Young, K Roberts, R Elmentaite, ... bioRxiv, 2020 | 1 | 2020 |
| Tumor to normal single-cell mRNA comparisons reveal a panneuroblastoma cancer cell (vol 5, eabd3311, 2021) G Kildisiute, WM Kholosy, MD Young, K Roberts, R Elmentaite, ... SCIENCE ADVANCES 8 (20), 2022 | | 2022 |
| P06. 01 αβ-T cells engineered to express γδ-T cell receptors can kill neuroblastoma organoids independent of MHC-I expression JGM Strijker, E Drent, JJF van der Hoek, R Pscheid, B Koopmans, K Ober, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 1), 2021 | | 2021 |
| P05. 01 Organoid-specific optimization of killing assays to test novel immunotherapies in a high-throughput system F van den Ham, WM Kholosy, K Ober, AM Cornel, S Nierkens, J Anderson, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 1), 2021 | | 2021 |
| P02. 02 Single-cell RNA sequencing of neuroblastoma tumors reveals immunoregulatory interactions as novel targets for immunotherapy J Wienke, WM Kholosy, LL Visser, KM Keller, P Lijnzaad, T Margaritis, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 1), 2021 | | 2021 |
| Sensitive Detection of Cell-Free Neuroblastoma DNA by Hypermethylated RASSF1A and Tumor Specific DNA Breakpoints L Van Zogchel, N Lak, E Van Wezel, I Sergeeva, H Feitsma, J Stutterheim, ... PEDIATRIC BLOOD & CANCER 67, S58-S59, 2020 | | 2020 |
| Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now K Langenberg, W Kholosy, L Schild, W Breunis, B Koopmans, J Koster, ... PEDIATRIC BLOOD & CANCER 66, S432-S432, 2019 | | 2019 |
